Evidence map›Paper›PMID 33264368›Full record

ArticlePloS one2020

How long should the COVID-19 lockdown continue?

Jonathan Caulkins, Dieter Grass, Gustav Feichtinger, Richard Hartl, Peter M Kort, Alexia Prskawetz, Andrea Seidl, Stefan Wrzaczek

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Path integral control of a stochastic multi-risk SIR pandemic model.Theory in biosciences = Theorie in den Biowissenschaften · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The optimal lockdown intensity for COVID-19.Journal of mathematical economics · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jonathan CaulkinsHeinz College, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America.ORCID 0000-0002-7748-9989
Dieter GrassInternational Institute for Applied Systems Analysis (IIASA), Laxenburg, Austria.
Gustav FeichtingerResearch Unit Operations Research and Control Systems (ORCOS), Institute of Statistics and Mathematical Methods in Economics, Vienna University of Technology, Vienna, Austria.
Richard HartlDepartment of Business Decisions and Analytics, University of Vienna, Vienna, Austria.ORCID 0000-0002-0461-0979
Peter M KortTilburg School of Economics and Management, Tilburg University, Tilburg, Netherlands.
Alexia PrskawetzWittgenstein Centre for Demography and Global Human Capital (Univ. Vienna, IIASA, VID/OAW), Vienna, Austria.
Andrea SeidlDepartment of Business Decisions and Analytics, University of Vienna, Vienna, Austria.
Stefan WrzaczekWittgenstein Centre for Demography and Global Human Capital (Univ. Vienna, IIASA, VID/OAW), Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nations struggled to decide when and how to end COVID-19 inspired lockdowns, with sharply divergent views between those arguing for a resumption of economic activity and those arguing for continuing the lockdown in some form. We examine the choice between continuing or ending a full lockdown within a simple optimal control model that encompasses both health and economic outcomes, and pays particular attention to when need for care exceeds hospital capacity. The model shows that very different strategies can perform similarly well and even both be optimal for the same relative valuation on work and life because of the presence of a so-called Skiba threshold. Qualitatively the alternate strategies correspond to trying essentially to eradicate the virus or merely to flatten the curve so fewer people urgently need healthcare when hospitals are already filled to capacity.

Indexed as

COVID-19Health PolicyHumansModels, StatisticalQuarantineTime Factors

Identifiers

PMID33264368
PMCPMC7710360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.